Search Results - "Novosad, O I"

The influence of GSTP1 A313G polymorphism on susceptibility, chemotherapy-related toxicity and prognosis of Hodgkin’s lymphoma in Ukrainian patients by Kriachok, I. A., Khranovska, N. M., Svergun, N. M., Filonenko, K. S., Novosad, O. I., Titorenko, I. B., Martynchik, A. V., Gubareva, H. O., Kadnikova, T. V., Aleksik, O. M., Kushchevyy, E. V., Pastushenko, I. V.

Get full text

PROGNOSTIC RISK FACTORS FOR NEWLY DIAGNOSED PATIENTS WITH ADVANCED STAGES CLASSICAL HODGKIN'S LYMPHOMA by Novosad, O I, Kriachok, I A, Grabovyy, O M, Antonuk, S A

“…Determination the complex of new prognostic risk factors will optimize and improve treatment and survival of patients with primary Hodgkin's Lymphoma…”
Get more information

Experience of using thalidomide in the treatment of patients with multiple myeloma by Novosad, O I, Kriachok, I A, Kadnikova, T V, Tytorenko, I B, Sychova, T V, Kostiukova, N I

“…The results of treatment of patients with multiple myeloma with thalidomide and complications of this treatment are presented. Monotherapy with thalidomide and…”
Get more information

Thromboprophylaxis in patients with multiply myeloma who receives chemotherapy with thalidomide by Novosad, O I, Kriachok, I A, Kadnikova, T V, Filonenko, K S, Tytorenko, I B, Martynchyk, A V, Aleksyk, O M, Gusachenko, Iu O, Filonenko, I A

“…Achievements of world practice about development and prophilaxis of tromboembolic events (VTE) in cancer patients. Particular attention is paid to prevention…”
Get more information

Efficiency therapy with rituximab in patients with non-Hodgkin's lymphomas by Kriachok, I A, Filonenko, K S, Gubareva, G O, Tytorenko, I B, Novosad, O I, Kadnikova, T V, Aleksik, O M, Martynchyk, A V, Kushchevyĭ, É V, Pastushenko, Ia V, Kutsenko, L B

“…Management of non-Hodgkin's lymphomas (NHL) has been significantly changed during last 40 years from radiotherapy to modern polychemotherapy with application…”
Get more information

The treatment of patients with refractory forms of Hodgkin's lymphomas by Hubareva, H O, Kriachok, I A, Tytorenko, I B, Aleksyk, O M, Novosad, O I, Kadnikova, T V, Martynchyk, A V, Pastushenko, Ia V, Filonenko, K S, Kushchevyĭ, Ie V

“…The treatment of patients with refractory forms of Hodgkin's lymphomas in combination with chemo-radiotherapy is priority. Nevertheless, chemotherapy has to…”
Get more information